Impact of PCV on Disease and Colonization Among Native American Communities
NCT01083459 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6628
Last updated 2015-01-19
Summary
The purpose of this study is to determine the impact of pneumococcal conjugate vaccine on carriage of pneumococcus in the nasopharynx and on the incidence of invasive pneumococcal disease in the community.
Conditions
- Pneumococcal Nasopharyngeal Colonization
- Invasive Pneumococcal Disease
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
Centers for Disease Control and Prevention
collaborator FED - collaborator INDUSTRY
-
Johns Hopkins Bloomberg School of Public Health
lead OTHER
Principal Investigators
-
Katherine L O'Brien, MD · Johns Hopkins Bloomberg School of Public Health
-
Lindsay R Grant, PhD · Johns Hopkins Bloomberg School of Public Health
Eligibility
- Min Age
- 7 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2012-04-30
- Completion
- 2012-04-30
Countries
- United States
Study Locations
More Related Trials
-
Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada
NCT01694329 ·Status: UNKNOWN
-
Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
NCT05092386 ·Status: COMPLETED ·Phase: PHASE1
-
PCV13 in Non-pregnant Papua New Guinean Women
NCT04183322 ·Status: COMPLETED
-
A Study to Assess the Impact of Pneumococcal Conjugate Vaccination Programme on the Carriage of Pneumococci
NCT01040143 ·Status: COMPLETED
-
Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly
NCT02451969 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization
NCT00508742 ·Status: COMPLETED ·Phase: PHASE3
-
Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)
NCT00560950 ·Status: COMPLETED ·Phase: PHASE3
-
Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.
NCT04583618 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Carriage of Pneumococci in Children Aged 1-5 Years, and Their Household Contacts
NCT02522546 ·Status: COMPLETED
-
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
NCT01654263 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease
NCT00457977 ·Status: COMPLETED ·Phase: PHASE3
-
PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)
NCT04974294 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A
NCT00839254 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age
NCT05489328 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population
NCT00327665 ·Status: COMPLETED ·Phase: PHASE1
-
Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage
NCT01109108 ·Status: COMPLETED
-
PPV: Pneumococcal Polysaccharide Vaccine in Older Adults
NCT00239694 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine
NCT05477693 ·Status: COMPLETED ·Phase: PHASE4
-
9-valent CRM 197 Pneumococcal
NCT00133549 ·Status: COMPLETED ·Phase: PHASE2
-
National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns
NCT04664556 ·Status: RECRUITING
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children
NCT00452452 ·Status: COMPLETED ·Phase: PHASE3
-
Pneumococcal Vaccination of Fiji Infants
NCT00170612 ·Status: COMPLETED ·Phase: PHASE2
-
Pneumonia Research and Vaccine Impact League
NCT03900520 ·Status: COMPLETED
-
Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae
NCT02116998 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I to Test a New Pneumococcal Vaccine
NCT03303976 ·Status: COMPLETED ·Phase: PHASE1